61314-624-94 : NDC 2026 Code

61314-624-94 : Ranibizumab-eqrn ( Cimerli )

Additionally :

You can get information about “61314-624-94” NDC code in 61314-624-94 in HTML format

HTML | 61314-624-94 in TXT (Plain Text) format

TXT | 61314-624-94 in PDF (Portable Document Format)

PDF | 61314-624-94 in XML format

XML formats.

NDC Code : 61314-624-94 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "61314-624-94",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94)  / .05 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "61314-0624-94",
    "ProductNDC": "61314-624",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cimerli",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ranibizumab-eqrn",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVITREAL",
    "StartMarketingDate": "20241212",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761165",
    "LabelerName": "Sandoz Inc",
    "SubstanceName": "RANIBIZUMAB",
    "StrengthNumber": ".3",
    "StrengthUnit": "mg/.05mL",
    "Pharm_Classes": "Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-08-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20241212",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}